Detalles de la búsqueda
1.
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Future Oncol
; 18(23): 2593-2604, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722877
2.
A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer.
Mol Ther
; 29(10): 2963-2978, 2021 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34023505
3.
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.
Lancet Oncol
; 21(7): 914-922, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32539942
4.
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab.
Acta Oncol
; 59(9): 1058-1063, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32762415
5.
Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.
Future Oncol
; 15(23): 2743-2757, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31339060
6.
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Cancer Treat Rev
; 121: 102648, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918169
7.
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Lung Cancer
; 186: 107417, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918061
8.
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
J Thorac Oncol
; 18(8): 1070-1081, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094664
9.
Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.
Front Oncol
; 12: 902967, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756673
10.
Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Cancers (Basel)
; 14(2)2022 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053597
11.
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC.
Front Immunol
; 13: 987639, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203609
12.
Comparative assessment of early mortality risk upon immune checkpoint inhibitors alone or in combination with other agents across solid malignancies: a systematic review and meta-analysis.
Eur J Cancer
; 177: 175-185, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368251
13.
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
Clin Lung Cancer
; 23(1): e17-e28, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34334296
14.
Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(7): e489-e499, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948460
15.
Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis.
JTO Clin Res Rep
; 3(8): 100335, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35619644
16.
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy.
Thorac Cancer
; 13(3): 483-488, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34939342
17.
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Front Oncol
; 12: 1078822, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755856
18.
Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Crit Rev Oncol Hematol
; 160: 103299, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33722699
19.
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Cancers (Basel)
; 13(6)2021 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33803958
20.
Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors.
J Pers Med
; 11(5)2021 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34069851